CSCCC(N/C=C1\C(=O)NC(=O)N(c2ccc(Br)cc2)C1=O)C(=O)OC(C)(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?